H&E: Hematoxylin and Eosin. HF Diet: High fat diet. HFHC Diet: High fat, high cholesterol diet. NAFLD:
INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD), defined as increased lipid deposition within hepatocytes in the absence of viral hepatitis or excessive alcohol consumption, is extremely common affecting 15-46% of adults in the United States (1) (2) (3) . However, the majority of patients with NAFLD have "simple steatosis" defined by hepatic steatosis in the absence of substantial inflammation or fibrosis. Such patients generally have a benign clinical course with a very low probability of developing progressive liver dysfunction and cirrhosis (4) .
In contrast, 10-30% of patients with NAFLD develop a more aggressive condition known as nonalcoholic steatohepatitis (NASH)(3), characterized by varying degrees of hepatic inflammation, balloon hepatocytes and fibrosis in addition to hepatic steatosis. Steatohepatitis can progress to cirrhosis, liver failure and hepatocellular carcinoma in a variable proportion of patients (4) (5) .
It is clearly established that central obesity and insulin resistance are important risk factors for the development of hepatic steatosis. However, the factor(s) responsible for the development of progressive steatohepatitis remain unclear. Determining these factors would: (1) Clarify the pathogenesis of progressive steatohepatitis; (2) Help to distinguish the sub-group of patients with NAFLD who are likely to develop progressive NASH and cirrhosis; (3) Potentially point to targeted treatments.
Recent reports by our group and others suggest that dietary and hepatic cholesterol are critical factors in the development of steatohepatitis in animal models (6) (7) (8) (9) . Human studies also support the hypothesis that dietary cholesterol plays a role in the development of steatohepatitis. In a large, nationally-representative epidemiological study, we reported that dietary cholesterol consumption was independently associated with the development of cirrhosis (10) . Finally, inhibition of intestinal cholesterol absorption by administration of ezetimibe to patients with NASH (11) (12) , has been reported to improve hepatic inflammation and steatosisthese studies were not, however, randomized or controlled.
Cholesterol, a naturally occurring molecule abundant in most tissues, has traditionally been viewed as inert. Recently, however, its crystalline form has been shown to induce inflammation by stimulating the NLRP3 by guest, on January 20, 2018 www.jlr.org
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METHODS
Patients with simple steatosis or steatohepatitis
From an existing human liver biorepository at Veterans Affairs Puget Sound Health Care System (VAPSHCS), we randomly selected 4 patients with histological NASH, defined as NAFLD Activity Score (NAS) of 5 or greater, with at least 1 point in each of the three components of the NAS score [steatosis 0-3, lobular inflammation 0-3, ballooning degeneration 0-2]; and 3 patients with histological simple steatosis, defined as NAS score 2-3 with no ballooning degeneration(15). We retrieved liver tissue from these patients that had been flash frozen in liquid nitrogen immediately after liver biopsy. Fasting laboratory tests were prospectively performed just prior to liver biopsy as well as completion of questionnaires and collection of demographic and clinical information.
Mice with simple steatosis or steatohepatitis
Male C57BL/6J littermate mice were fed for 30 weeks either a high-fat (15%, w/w) diet with no cholesterol ("HF" diet, n=8) or a high-fat (15%), high-cholesterol (1%) diet ("HFHC" diet, n=8). The experimental diets were prepared by Bioserve (Frenchtown, NJ) and their composition is described in Supplementary Table 1. Mice were euthanized 30 weeks after initiation of the experimental diets by cervical dislocation following isoflurane anesthesia. We previously reported that mice fed a HF diet developed increased hepatic fat deposition with little inflammation and no fibrosis (simple steatosis) (16) . Mice on a HFHC diet developed significantly more profound hepatic steatosis, substantial inflammation and perisinusoidal fibrosis (steatohepatitis), associated with adipose tissue inflammation and a reduction in plasma adiponectin levels (16) .
Hepatic Histology
by guest, on January 20, 2018 www.jlr.org
Downloaded from
Formalin-fixed liver sections: Human and mouse formalin-fixed, paraffin-embedded liver tissue was sectioned and stained with hematoxylin and eosin (H&E) and with Masson's trichrome or Sirius red (for collagen).
Histological steatosis, inflammation, and fibrosis were assessed semi-quantitatively by a "blinded" liver pathologist according to the scoring system proposed by Brunt et al. and recently modified by Kleiner et al(15) .
Frozen liver sections: Human liver biopsies were placed in cyrovials and frozen in liquid nitrogen immediately after liver biopsy. Just prior to cutting, the frozen human livers were embedded in Optimal Cutting Temperature (OCT) compound and frozen on dry ice. Mouse liver portions were embedded in OCT and frozen in liquid nitrogen immediately after removal. Frozen sections (10µM in thickness) were allowed to come to room temperature, immediately cover-slipped using pure glycerol as the mounting medium without applying any stain, and examined using a Nikon Eclipse microscope with or without a polarizing filter, to evaluate for the presence of birefringent crystals.
Staining for unesterified "free" cholesterol: Frozen liver sections were stained with filipin, which identifies free cholesterol by interacting with its 3β-hydroxy group (17) , as follows. After fixing for 15 minutes in formalin, liver sections were washed with phosphate buffered saline (PBS), and then treated with 10% fetal bovine serum (FBS) in PBS for 30 minutes. Filipin (Sigma Chemical Co., St. MO) was dissolved in a small volume of dimethysulfoxide (DMSO) then diluted to 0.25 mg/ ml in 10%FBS/ PBS and added to the tissue for 1 hour at room temperature. Slides were washed with 10%FBS/ PBS once and PBS twice. Slides were cover-slipped using Aquamount (Lerner, Pittsburgh, PA) and examined using a fluorescent Nikon Eclipse microscope with the DAPI filter in place.
Staining for macrophages: Frozen mouse and human sections were stained with anti-CD68 antibodies, which identify macrophages (including hepatic Kupffer cells), followed by secondary antibodies labeled with AlexaFluor 488 (Invitrogen, Camarillo, CA) and then examined using a fluorescent microscope. To determine whether macrophages were activated, mouse liver sections were also stained with rat anti-mouse CD11b ( by guest, on January 20, 2018 www.jlr.org Downloaded from also known as macrophage-1 antigen or Mac-1) antibodies identified by a goat anti-rat secondary antibody linked to horseradish peroxidase or with anti-TNFα antibodies identified by secondary antibodies labeled with AlexaFluor 488. We will henceforth use the term "Kupffer cells" (resident, tissue macrophages of the liver) to describe CD68-positive cells, while acknowledging that some of these cells may be macrophages recruited from the circulation.
Electron Microscopy
At time of tissue removal, pieces of mouse or human liver were fixed in Trump's fixative. After post-fixation in osmium tetroxide, the samples were embedded in epoxy resin and thinly sliced (0.12 µM). The sections were stained with a solution of uranyl acetate followed by aqueous lead citrate and viewed using a Jeol (Tokyo, Japan) transmission electron microscope. Thicker sections (1 µM) of the embedded tissue that had been fixed in osmium tetroxide were counter-stained with methylene blue and viewed under regular light microscope.
Osmium tetroxide binds at the carbon-carbon double bonds of unsaturated fatty acids and therefore could potentially distinguish lipid droplets that contained only free cholesterol (no staining with osmium) from lipid droplets that contained triglycerides or cholesterol esters.
Hepatic Lipid Analysis
Lipids were extracted from frozen mouse liver using the Folch method (18) . The neutral lipid fractions were prepared by solid phase extraction on Bond Elut Si cartridges (Varian Corp, Walnut Creek, CA) and the triglycerides, diglycerides, cholesterol esters and free cholesterol were then separated and quantified by normal phase HPLC/ELSD. Free fatty acids were esterified by boron trifluoride/methanol and the methyl esters then separated by GC, using a 60m HP-Innowax capillary column (Agilent Technologies, Santa Clara, CA).
Insufficient frozen human liver tissue was available to perform hepatic lipid analysis. 
Hepatic mRNA analysis
Total RNA was isolated from mouse liver tissue using RNeasy miniColumns (Qiagen, Valencia, CA) and reverse transcribed to cDNA. Quantitative real time RT-PCR was performed using the ABI 7500 sequence detection system (Applied Biosystems, Foster City, CA) with β-actin as the housekeeping gene. The hepatic gene expression levels of 4 genes related to the NLRP3 inflammasome were assessed (Nalp3, ASC [apoptosisassociated speck-like, caspase recruitment domain containing protein], Caspase-1 and Pannexin-1) (19) because cholesterol crystals have been shown to induce inflammation by stimulating the NLRP3 inflammasome in animal models of atherosclerosis (13) . Gene expression studies were only performed on mouse liver tissue.
Institutional Approvals
All experimental procedures were undertaken with approval from the Institutional Review Board and the Institutional Animal Care and Use Committee of the Veterans Affairs Puget Sound Health Care System. Human subjects provided informed consent for participation in our biorepository. Animal investigations conformed with the Public Health Policy on Humane Care and Use of Laboratory animals.
RESULTS
All patients with NASH (n=4) or simple steatosis (n=3) were obese, male, with mildly elevated serum ALT level and normal serum bilirubin level (Table 1 ). All patients with NASH had diabetes mellitus while only one of three patients with simple steatosis had diabetes.
Mice fed a HFHC diet developed steatohepatitis and had higher body weight and liver weight, higher hepatic triglyceride, diglyceride, cholesterol ester and free cholesterol concentration, higher plasma ALT, cholesterol and insulin levels and lower serum adiponectin levels than mice fed a HF diet, which developed simple steatosis ( Table 2 ).
Light microscopy of formalin-fixed, human and mouse liver sections, stained with H&E, Sirius red and In contrast, mouse and human frozen liver sections with simple steatosis did not have any birefringent material and did not stain with filipin within hepatocyte lipid droplets (Figures 2 and 3) , suggesting absence of
DISCUSSION
Our results show that cholesterol crystals were present within steatotic hepatocytes in patients with NASH and in a mouse model of NASH induced by HFHC diet, but not in patients or mice with simple steatosis.
Enlarged Kupffer cells surrounded steatotic, dead hepatocytes that included cholesterol crystals and appeared to process the remnant lipid droplets within these hepatocytes, forming "crown-like structures" similar to those recently described in inflamed, visceral adipose tissue (20) (21) . This lipid scavenging resulted in profound accumulation of cholesterol within small droplets in markedly enlarged, activated Kupffer cells that took the appearance of lipid-laden "foam cells". This process may represent an important pathogenetic mechanism in NASH since exposure of macrophages to excess free cholesterol and cholesterol crystals has been shown to lead to their activation (13) .
Several recent lines of evidence suggest that dietary cholesterol plays an important role in the pathogenesis of NASH. We reported that addition of dietary cholesterol to a high fat diet causes progression from simple steatosis to steatohepatitis in C57BL/6J mice (16) . Addition of dietary cholesterol to a high-fat, high-carbohydrate, diabetogenic diet led to increased hepatic steatosis, inflammation and fibrosis in LDL receptor deficient mice(8). Addition of cholesterol to the diet of Alms1 mutant (foz/foz) mice, which are obese and insulin resistant, led to accumulation of hepatic free cholesterol, hepatocyte apoptosis, macrophage recruitment and liver fibrosis (9) . Administration of a liver X receptor (LXR) agonist to hyperlipidemic mice with NASH decreases hepatic accumulation of free cholesterol and increases hepatic accumulation of triglyceride, accompanied by a decrease in hepatic inflammation (22) . Thus, in that experimental model, the effects of triglycerides (responsible for most of the observed "steatosis") were dissociated from the effects of free cholesterol (potentially responsible for the inflammation) (22) .
How exposure of the liver to excess cholesterol might promote the progression of simple steatosis to steatohepatitis remains unclear. Our results suggest that a critical early step might be crystallization of cholesterol within fatty hepatocytes. We identified a striking association between the presence of cholesterol crystals within hepatocyte lipid droplets and the presence of NASH versus simple steatosis in both humans and mice. Although hepatocyte lipid droplets were readily evident both in NASH and simple steatosis, cholesterol crystals were present only in the lipid droplets of livers with NASH but not in the lipid droplets of livers with simple steatosis.
Moreover, the steatotic hepatocytes with strong birefringence were associated with striking changes in surrounding Kupffer cells, suggesting that the cholesterol crystals were more than innocent bystanders. Only Exposure of macrophages to excess free cholesterol and cholesterol crystals has been shown to lead to their activation (13) . Future studies that directly modulate cholesterol crystallization, macrophage aggregation, or inflammasome activation will be required to prove this proposed sequence of events.
In a series of excellent recent papers, Dutch investigators identified foamy Kupffer cells in the liver of LDL receptor-deficient mice fed a high-fat, high-cholesterol diet (22) (23) (24) (25) (26) . However, they postulated that this cholesterol was derived from uptake of modified circulating lipoproteins by scavenger receptors on the Kupffer cells(24-25). While this process may also be occurring, our results suggest that processing of remnant lipid droplets from dead, steatotic hepatocytes represents an important mechanism by which macrophages acquire cholesterol.
There are striking and potentially informative similarities between the hepatic "crown-like structures" we observed in NASH and the crown-like structures recently described in inflamed adipose tissue (20) (21) . In the latter, dead adipocytes were shown to be surrounded by macrophages that "scavenged" the residual adipocyte lipid droplet and ultimately formed multinucleate giant cells, a hallmark of chronic inflammation.
We observed the same enveloping and processing of dead, steatotic hepatocytes by Kupffer cells in NASH.
However, we additionally observed that the Kupffer cells became loaded with cholesterol-containing droplets (foam cells) which was not described in the case of adipose tissue macrophages. We believe that this is due to the high concentration of cholesterol (free and esterified) in the hepatic lipid droplets.
Inflammasomes are multiprotein complexes which, once activated, promote the maturation and release of pro-inflammatory interleukins via activation of caspase-1. Recent studies have suggested that activation of the NLRP3 inflammasome in hepatic Kupffer cells is an important trigger for inflammation in NASH and may, therefore, contribute to the progression from simple steatosis to NASH (27) (28) (29) . However, what may be activating the inflammasome in NASH was unclear. In the setting of atherosclerosis, cholesterol crystals have been shown recently to activate the NLRP3 inflammasome in macrophages (13) . Given these findings and our demonstration of cholesterol crystal-containing lipid being processed by Kupffer cells in NASH, it is tempting to speculate that cholesterol crystals activate the NLRP3 inflammasome in Kupffer cells triggering an inflammatory response and promoting progression from simple steatosis to NASH. We identified increased expression of NLRP3 genes in our mice with NASH compared to the mice with simple steatosis, but the difference was not statistically significant. The lack of statistical significance may not be surprising considering that NLRP3 genes are expressed primarily by Kupffer cells, which constitute less than 10% of all liver cells. Future studies will be needed to specifically prove this hypothesis.
Our study is limited by the small number of patients studied and the fact that patients with NASH were not matched to those with simple steatosis with respect to diabetes, obesity or insulin resistance. Future human studies with a larger sample size will be required to confirm the associations that we have described between hepatic cholesterol crystals and NASH and to determine if these associations are independent of potential confounders such as diabetes, insulin resistance and obesity.
Our results suggest that an important trigger for progression of simple steatosis to steatohepatitis (NASH) might be the accumulation of sufficient concentrations of free cholesterol within steatotic hepatocytes to cause crystallization of cholesterol. We identified a strong association between the presence of cholesterol crystals within hepatocyte lipid droplets, aggregation and activation of Kupffer cells in crown-like structures around such droplets, and the presence of NASH versus simple steatosis, in both humans and mice. Although hepatocyte lipid droplets were abundant in both NASH and simple steatosis, cholesterol crystals were observed only in the lipid droplets of livers with NASH. These associations need to be confirmed in larger numbers of human liver specimens and in additional animal models. The potential causative role of these associations deserves further examination in interventional studies. Livers with NASH exhibited strongly birefringent crystals within a large proportion of lipid droplets (2f, 2h and 3f, 3h) when viewed under polarized light. Filipin, which stains free cholesterol, also stained prominently the same droplets that had birefringence in livers with NASH, suggesting that the birefringence was due to cholesterol crystals. In contrast, livers with simple steatosis (a-d) did not exhibit any birefringence under polarized light despite having multiple lipid droplets within hepatocytes as seen in the bright field images (a) and did not contain excessive free cholesterol (absence of blue stain in c). . Liver sections of mice on HFHC diet (NASH) stained with osmium and methylene blue (a-c) or viewed with transmission electron microscopy (d-e). Osmium staining with methylene blue counterstaining readily identifies multiple crown like structures because the remnant lipid droplet of the dead hepatocyte does not take up osmium (marked with asterisks*) while all other normal lipid droplets in viable hepatocytes (marked "LD") take up osmium and stain gray/brown. Higher magnification of two of the crown-like structures in panel a is shown in panel b and c, demonstrating a granular precipitate within the remnant lipid droplets (marked with asterisks *) that are surrounded by Kupffer cells (white arrows). Panel c shows that the Kupffer cells acquire multiple, small, non-osmium binding cholesterol droplets (black arrow) as processing of the remnant lipid droplet of the dead hepatocyte advances. Crown-like structures viewed by electron microscopy are shown in 6d and 6e again demonstrating multiple Kupffer cells (white arrows) surrounding and processing remnant lipid droplets (marked with asterisks *) of dead hepatocytes. These remnant droplets do not take osmium (which is used in EM fixation) and are shown again to contain a granular precipitate in contrast to healthy hepatocyte lipid droplets (LD) that stain gray. In 6e the Kupffer cells have acquired multiple small cholesterol droplets (black arrow) turning into foam cells. The remnant lipid droplets of dead hepatocytes that do not stain with osmium correspond to the intensely birefringent droplets (Maltese crosses) seen by polarized light in 5b and 5d. 
